[The possibility of treatment of cognitive impairment in the complex therapy of patients with the consequences of cerebral infarction].

Kuznetsova EB, Salina EA, Sholomov II

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2015

PMID26978058DOI10.17116/jnevro2015115111103-106PepBankPUB-26978058

Publisher page PubMedAsk about this study

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, Cortexin (cortical polypeptide complex) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cortexin (cortical polypeptide complex).

01HumanNot a test of Cortexin (cortical polypeptide complex) aloneNon-randomized trialEfficacy outcome
In patients after cerebral infarction, combined cortexin and mexidol reduced complaints.
In plain wordsAfter cerebral infarction, combined cortexin and mexidol reduced complaints.
Peptide
Cortexin (cortical polypeptide complex)
Outcome
DecreaseComplaints
Study
n = 62
Outcome group
Overall treatment effect · Nervous system and cognition
Source sentences
Summary
It has been shown that the use of this drug combination decreasescomplaints and neurological symptoms and significantly improves cognitive and emotional status as well.
1 context sentence(design, population, supporting numbers)
Summary · context
We carried out a neurological and neuropsychological examination of 62 patients with the consequences of cerebral infarction treated with cortexin in the dose of 10 mg and mexidol in the dose of 5 mL of 5% solution intravenously during 15 days.
In this study, Cortexin (cortical polypeptide complex) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cortexin (cortical polypeptide complex).
Report a problemFND-2697805801
02HumanNot a test of Cortexin (cortical polypeptide complex) aloneNon-randomized trialEfficacy outcome
In patients after cerebral infarction, combined cortexin and mexidol reduced neurological symptoms.
In plain wordsAfter cerebral infarction, combined cortexin and mexidol reduced neurological symptoms.
Peptide
Cortexin (cortical polypeptide complex)
Outcome
DecreaseNeurological symptoms
Study
n = 62
Outcome group
Overall treatment effect · Nervous system and cognition
Source sentences
Summary
It has been shown that the use of this drug combination decreasescomplaints and neurological symptoms and significantly improves cognitive and emotional status as well.
1 context sentence(design, population, supporting numbers)
Summary · context
We carried out a neurological and neuropsychological examination of 62 patients with the consequences of cerebral infarction treated with cortexin in the dose of 10 mg and mexidol in the dose of 5 mL of 5% solution intravenously during 15 days.
In this study, Cortexin (cortical polypeptide complex) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cortexin (cortical polypeptide complex).
Report a problemFND-2697805802
03HumanNot a test of Cortexin (cortical polypeptide complex) aloneNon-randomized trialEfficacy outcome
In patients after cerebral infarction, combined cortexin and mexidol significantly improved cognitive status.
In plain wordsAfter cerebral infarction, combined cortexin and mexidol improved cognitive status.
Peptide
Cortexin (cortical polypeptide complex)
Outcome
IncreaseCognitive status
Study
n = 62
Outcome group
Cognition and memory · Nervous system and cognition
Source sentences
Summary
It has been shown that the use of this drug combination decreasescomplaints and neurological symptoms and significantly improves cognitive and emotional status as well.
1 context sentence(design, population, supporting numbers)
Summary · context
We carried out a neurological and neuropsychological examination of 62 patients with the consequences of cerebral infarction treated with cortexin in the dose of 10 mg and mexidol in the dose of 5 mL of 5% solution intravenously during 15 days.
In this study, Cortexin (cortical polypeptide complex) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cortexin (cortical polypeptide complex).
Report a problemFND-2697805803
04HumanNot a test of Cortexin (cortical polypeptide complex) aloneNon-randomized trialEfficacy outcome
In patients after cerebral infarction, combined cortexin and mexidol significantly improved emotional status.
In plain wordsAfter cerebral infarction, combined cortexin and mexidol improved emotional status.
Peptide
Cortexin (cortical polypeptide complex)
Outcome
IncreaseEmotional status
Study
n = 62
Outcome group
Anxiety and mood · Mental health and mood
Source sentences
Summary
It has been shown that the use of this drug combination decreasescomplaints and neurological symptoms and significantly improves cognitive and emotional status as well.
1 context sentence(design, population, supporting numbers)
Summary · context
We carried out a neurological and neuropsychological examination of 62 patients with the consequences of cerebral infarction treated with cortexin in the dose of 10 mg and mexidol in the dose of 5 mL of 5% solution intravenously during 15 days.
In this study, Cortexin (cortical polypeptide complex) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cortexin (cortical polypeptide complex).
Report a problemFND-2697805804

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
22 Oct 2026, 02:25 UTC
Study results updated
Version 1
21 Oct 2026, 18:59 UTC
First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

Journal Article

MeSH terms

PepBank is a research reference. Talk to a doctor before you use any peptide.